838 related articles for article (PubMed ID: 25743786)
41. Cpf1-assisted efficient genomic integration of in vivo assembled DNA parts in Saccharomyces cerevisiae.
Li ZH; Liu M; Wang FQ; Wei DZ
Biotechnol Lett; 2018 Aug; 40(8):1253-1261. PubMed ID: 29797148
[TBL] [Abstract][Full Text] [Related]
42. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
[TBL] [Abstract][Full Text] [Related]
43. Genome engineering using CRISPR-Cas9 system.
Cong L; Zhang F
Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
[TBL] [Abstract][Full Text] [Related]
44. Plasmids for in vivo construction of integrative Candida albicans vectors in Saccharomyces cerevisiae.
Vieira N; Pereira F; Casal M; Brown AJ; Paiva S; Johansson B
Yeast; 2010 Nov; 27(11):933-9. PubMed ID: 20602447
[TBL] [Abstract][Full Text] [Related]
45. Preloading budding yeast with all-in-one CRISPR/Cas9 vectors for easy and high-efficient genome editing.
Degreif D; Kremenovic M; Geiger T; Bertl A
J Biol Methods; 2018; 5(3):e98. PubMed ID: 31453248
[TBL] [Abstract][Full Text] [Related]
46. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
[TBL] [Abstract][Full Text] [Related]
47. CRISPR/Cas9-RNA interference system for combinatorial metabolic engineering of Saccharomyces cerevisiae.
Kildegaard KR; Tramontin LRR; Chekina K; Li M; Goedecke TJ; Kristensen M; Borodina I
Yeast; 2019 May; 36(5):237-247. PubMed ID: 30953378
[TBL] [Abstract][Full Text] [Related]
48. A simple and rapid approach to manipulate pseudorabies virus genome by CRISPR/Cas9 system.
Xu A; Qin C; Lang Y; Wang M; Lin M; Li C; Zhang R; Tang J
Biotechnol Lett; 2015 Jun; 37(6):1265-72. PubMed ID: 25724716
[TBL] [Abstract][Full Text] [Related]
49. A CRISPR/Cas9 toolkit for multiplex genome editing in plants.
Xing HL; Dong L; Wang ZP; Zhang HY; Han CY; Liu B; Wang XC; Chen QJ
BMC Plant Biol; 2014 Nov; 14():327. PubMed ID: 25432517
[TBL] [Abstract][Full Text] [Related]
50. Metabolic engineering of Saccharomyces cerevisiae using the CRISPR/Cas9 system to minimize ethyl carbamate accumulation during Chinese rice wine fermentation.
Wu D; Xie W; Li X; Cai G; Lu J; Xie G
Appl Microbiol Biotechnol; 2020 May; 104(10):4435-4444. PubMed ID: 32215703
[TBL] [Abstract][Full Text] [Related]
51. A CRISPR/Cas9-based exploration into the elusive mechanism for lactate export in Saccharomyces cerevisiae.
Mans R; Hassing EJ; Wijsman M; Giezekamp A; Pronk JT; Daran JM; van Maris AJA
FEMS Yeast Res; 2017 Dec; 17(8):. PubMed ID: 29145596
[TBL] [Abstract][Full Text] [Related]
52. Construction of integrative plasmids suitable for genetic modification of industrial strains of Saccharomyces cerevisiae.
Leite FC; Dos Anjos RS; Basilio AC; Leal GF; Simões DA; de Morais MA
Plasmid; 2013 Jan; 69(1):114-7. PubMed ID: 23041652
[TBL] [Abstract][Full Text] [Related]
53. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
54. Plasmid-free CRISPR/Cas9 genome editing in Saccharomyces cerevisiae.
Nishimura A; Tanahashi R; Oi T; Kan K; Takagi H
Biosci Biotechnol Biochem; 2023 Mar; 87(4):458-462. PubMed ID: 36694939
[TBL] [Abstract][Full Text] [Related]
55. SWITCH: a dynamic CRISPR tool for genome engineering and metabolic pathway control for cell factory construction in Saccharomyces cerevisiae.
Vanegas KG; Lehka BJ; Mortensen UH
Microb Cell Fact; 2017 Feb; 16(1):25. PubMed ID: 28179021
[TBL] [Abstract][Full Text] [Related]
56. Construction of Designer Selectable Marker Deletions with a CRISPR-Cas9 Toolbox in
Zhao Y; Boeke JD
G3 (Bethesda); 2018 Mar; 8(3):789-796. PubMed ID: 29321167
[TBL] [Abstract][Full Text] [Related]
57. Construction of a large plasmid lacking linearizing single restriction sites by simultaneous in vivo recombination and plasmid shuffling in yeast.
Miletti KE; Leibowitz MJ
Yeast; 2000 Dec; 16(16):1527-34. PubMed ID: 11113975
[TBL] [Abstract][Full Text] [Related]
58. CRISPRing into the woods.
Tsai CJ; Xue LJ
GM Crops Food; 2015; 6(4):206-15. PubMed ID: 26357840
[TBL] [Abstract][Full Text] [Related]
59. Development of a mono-promoter-driven CRISPR/Cas9 system in mammalian cells.
Yoshioka S; Fujii W; Ogawa T; Sugiura K; Naito K
Sci Rep; 2015 Dec; 5():18341. PubMed ID: 26669567
[TBL] [Abstract][Full Text] [Related]
60. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
